SeaSpine Makes Ambitious Investment for 2021 Growth

SeaSpine's logo

SeaSpine reported 2Q21 orthopedic revenue of $47.5 million, +66.1% vs. 2Q20. Compared to the second quarter of 2019, the company's sales grew +20.8%. The company raised the bottom of its previously stated guidance, now at a range of $201 million to $205 million. This reflects growth of +30% to +33% vs. 2020.

The company remains "cautiously...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us